성운파마코피아의 포트폴리오를 소개합니다
| Description | |
| Product Name | Efavirenz |
| Synonym | (4S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one |
| Product Information | |
| Cas Registration No. | 154598-52-4 |
| Chemical Formula | C14H9ClF3NO2 |
| Molecule Weight | 315.67 |
| HS Code | |
| Application | Efavirenz is a nonnucleoside reverse transcriptase inhibitor (NNRTI). It is an anti-HIV drug, commonly used in combination therapy for AIDs treatment. It is part of highly active antiretroviral therapy (HAART) for the treatment of a human immunodeficiency virus (HIV) type 1. |
| Characteristics | |
| Quality Specification | |
| Appearance | White to off white Powder |
| Dose Form | Oral Grade |
| Specification | USP |
| Storage / Packing Information | |
| Storage | Room Temperature |
| Packing Unit | 1KG / 25KG / 100KG / 250KG / 1MT |
| Custom Information | |
| GMP | GMP, PIC/S |
| DMF | DMF in CTD |
| Development | Commercialized |